Taken together, the AC serum effectively relieved the indicators of inflammation and down-regulating the expression of colon cancer biomarker CXCL8 as determined by bioinformatics analysis but has no impact on another pro-inflammatory chemokine IL6. The gene discussed is CXCL8; the disease is colonic neoplasm.